Category: Obesity

Posted on Posted in All Podcasts, Cancer, Diabetes, Health Newsfeed, Obesity
Play

Podcast: Download (Duration: 1:08 — 1.6MB)

Subscribe: RSS

A blood test used for population based cancer screening fell short of allowing cancers to be detected earlier, was cost prohibitive and delayed diagnoses for others, a new study shows. Johns Hopkins Kimmel Cancer Center director William Nelson says both …

What do false positives and negatives have to do with screening tests for cancer? Elizabeth Tracey reports Read more »

Posted on Posted in All Podcasts, Cancer, Diabetes, Health Newsfeed, Obesity
Play

Podcast: Download (Duration: 1:05 — 1.5MB)

Subscribe: RSS

A blood test capable of detecting multiple cancers seems like a dream come true, yet a new study looking at such a test used in populations of people failed to find cancers earlier, and also delayed diagnosis for others. William …

Just how expensive could it be to screen populations of people for cancer using blood tests? Elizabeth Tracey reports Read more »

Posted on Posted in All Podcasts, Cancer, Diabetes, Health Newsfeed, Obesity
Play

Podcast: Download (Duration: 1:06 — 1.5MB)

Subscribe: RSS

When large populations of people were screened for multiple cancers using a blood test, not only didn’t cancers get found earlier, others who were not screened had delays in their diagnosis and treatment of cancer. Johns Hopkins Kimmel Cancer Center …

Should blood tests to screen for cancer be used on a population basis? Elizabeth Tracey reports Read more »

Posted on Posted in All Podcasts, Cancer, Diet, Health Newsfeed, Obesity
Play

Podcast: Download (Duration: 1:03 — 1.5MB)

Subscribe: RSS

For some types of cancer obesity is clearly a risk factor. Now a new study shows that when people with obesity take a GLP-1 agonist to lose weight, they also reduce their risk for these cancers. Kimmel Cancer Center director …

How do GLP-1 agonists compare against other strategies for weight reduction and cancer risk reduction? Elizabeth Tracey reports Read more »

Posted on Posted in All Podcasts, Cancer, Diabetes, Health Newsfeed, Obesity
Play

Podcast: Download (Duration: 1:04 — 1.5MB)

Subscribe: RSS

GLP-1 agonists are a class of drugs originally developed to treat diabetes but have been shown to be helpful for weight loss. Now a new study looks at whether their use reduces the risk of obesity related cancers. William Nelson, …

How are one class of diabetes drugs related to cancer risk? Elizabeth Tracey reports Read more »

Posted on Posted in All Podcasts, Health Newsfeed, Heart And Vascular, Obesity
Play

Podcast: Download (Duration: 1:06 — 1.5MB)

Subscribe: RSS

The good news is heart failure in people with severe obesity may be reversible with common weight loss drugs. The bad news is both obesity, with BMIs of around 30, and severe obesity, with a BMI of 42 or greater, …

Increasing rates of obesity and severe obesity may presage increased rates of heart failure, Elizabeth Tracey reports Read more »

Posted on Posted in All Podcasts, Health Newsfeed, Heart And Vascular, Obesity
Play

Podcast: Download (Duration: 1:04 — 1.5MB)

Subscribe: RSS

GLP-1 receptor agonists are effective in helping most people lose weight, and now a new study suggests that in those with severe obesity, a BMI of 42 or greater and who have a type of heart failure, this condition may …

Is there another benefit besides weight loss of GLP-1s in people with severe obesity? Elizabeth Tracey reports Read more »